Stivarga (regorafenib) — Medica
Bone cancer (osteosarcoma, Ewing sarcoma)
Initial criteria
- age ≥ 18 years
- relapsed/refractory or metastatic disease
- tried one systemic chemotherapy regimen (examples: cisplatin, doxorubicin, methotrexate, ifosfamide, cyclophosphamide, etoposide, topotecan, irinotecan, vincristine, temozolomide)
- diagnosis of Ewing sarcoma OR osteosarcoma
Approval duration
1 year